T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.45B |
| 2 |
JPMorgan Chase
JPM
|
+$2.22B |
| 3 |
Atlassian
TEAM
|
+$2.08B |
| 4 |
NVIDIA
NVDA
|
+$1.81B |
| 5 |
Apple
AAPL
|
+$1.67B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$3.24B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.08B |
| 3 |
Microsoft
MSFT
|
+$2.68B |
| 4 |
Wells Fargo
WFC
|
+$1.93B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$1.86B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.79% |
| 2 | Healthcare | 17.19% |
| 3 | Consumer Discretionary | 15.16% |
| 4 | Financials | 10.74% |
| 5 | Communication Services | 10.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2726
PharmaCyte Biotech
PMCB
$5.9M
| $180K | ﹤0.01% |
78,100
| – | – |
|
2727
CleanSpark
CLSK
$2.96B
| $178K | ﹤0.01% |
14,410
-1,564
| -10% | -$14.5K |
|
|
MITT
2728
TPG Mortgage Investment Trust
MITT
$214M
| $177K | ﹤0.01% |
19,000
-7,000
| -27% | -$67.3K |
|
2729
Workhorse Group
WKHS
$33.1M
| $176K | ﹤0.01% |
12
+4
| +50% | +$44.1K |
|
2730
Genprex
GNPX
$2.46M
| $174K | ﹤0.01% |
2
| – | – |
|
2731
4D Molecular Therapeutics
FDMT
$609M
| $172K | ﹤0.01% |
11,375
+700
| +7% | +$11K |
|
2732
Ribbon Communications
RBBN
$377M
| $172K | ﹤0.01% |
55,674
+13,000
| +30% | +$53.3K |
|
2733
Ocean Power Technologies
OPTT
$55.4M
| $169K | ﹤0.01% |
119,800
| – | – |
|
2734
Porch Group
PRCH
$1.92B
| $169K | ﹤0.01% |
24,366
+1,650
| +7% | +$15.2K |
|
|
GRTS
2735
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
| $169K | ﹤0.01% |
41,099
+12,143
| +42% | +$64.3K |
|
|
LUNA
2736
DELISTED
Luna Innovations Incorporated
LUNA
| $169K | ﹤0.01% |
21,947
+5,932
| +37% | +$42.7K |
|
|
YMAB
2737
DELISTED
Y-mAbs Therapeutics
YMAB
| $168K | ﹤0.01% |
+14,165
| New | +$145K |
|
|
PRTY
2738
DELISTED
Party City Holdco Inc.
PRTY
| $167K | ﹤0.01% |
46,723
+3,637
| +8% | +$16.5K |
|
2739
Grid Dynamics Holdings
GDYN
$644M
| $165K | ﹤0.01% |
11,714
+4,109
| +54% | +$84K |
|
2740
NovaGold Resources
NG
$3.4B
| $164K | ﹤0.01% |
21,280
+5,376
| +34% | +$37.8K |
|
2741
NN Inc
NNBR
$298M
| $164K | ﹤0.01% |
56,973
+10,316
| +22% | +$34K |
|
2742
Tencent Music
TME
$14.2B
| $163K | ﹤0.01% |
33,400
+4,600
| +16% | +$25.9K |
|
|
CSSE
2743
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
| $162K | ﹤0.01% |
20,244
+5,800
| +40% | +$60.6K |
|
|
EPZM
2744
DELISTED
Epizyme, Inc
EPZM
| $162K | ﹤0.01% |
141,097
+83,839
| +146% | +$137K |
|
2745
Genie Energy
GNE
$386M
| $161K | ﹤0.01% |
23,842
| – | – |
|
2746
Acacia Research
ACTG
$449M
| $157K | ﹤0.01% |
34,795
+1,200
| +4% | +$5.04K |
|
2747
GrowGeneration
GRWG
$108M
| $157K | ﹤0.01% |
+17,027
| New | +$153K |
|
2748
Precigen
PGEN
$2.32B
| $157K | ﹤0.01% |
74,266
+9,400
| +14% | +$22.9K |
|
|
PPSI
2749
Pioneer Power Solutions
PPSI
$33.5M
| $157K | ﹤0.01% |
27,800
-41,600
| -60% | -$266K |
|
2750
American Well
AMWL
$220M
| $156K | ﹤0.01% |
1,848
+771
| +72% | +$65.1K |
|
Similar funds
T. Rowe Price Associates's Q1 2022 Portfolio in Review
As of Q1 2022, T. Rowe Price Associates held 3,085 positions worth $992B, down 11% from $1.11T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q1 2022 filing shows 108 new, 1,637 increased, 1,059 reduced and 107 closed positions. Its largest new stake was Nutrien: 6,143,560 shares worth $639M. The largest sale was Alphabet (Google) Class C, an estimated $3.24B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 27% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2022 buy was Nutrien: 6,143,560 shares worth $639M.
- T. Rowe Price Associates added most to Tesla in Q1 2022, an estimated $4.45B increase.
- T. Rowe Price Associates's biggest Q1 2022 reduction was Alphabet (Google) Class C, cutting an estimated $3.24B.
- T. Rowe Price Associates fully exited Xilinx Inc in Q1 2022, selling an estimated $481M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $992B portfolio in Q1 2022.
- T. Rowe Price Associates opened 108 new positions and closed 107 in Q1 2022.
- T. Rowe Price Associates's portfolio value fell 11% quarter-over-quarter to $992B.
Based on T. Rowe Price Associates's 13F filing for Q1 2022, filed 16 May 2022.